Kinesio Taping and Inhibitory Treatment Techniques

September 20, 2023 updated by: Adelaida María Castro-Sánchez, Universidad de Almeria

Benefits of Kinesio Taping and Inhibitory Treatment Techniques in Patients With Fibromyalgia Syndrome

Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS).

Study Design: A single-blind randomized controlled trial was conducted on patients with FMS.

Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.

Study Overview

Status

Suspended

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
      • Almería, Spain, 04120
        • Adelaida María Castro-Sánchez

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed Fibromyalgia Syndrome.
  • Limitation of usual activities due to pain on at least 1 day in the previous 30 days.
  • Agreement to attend evening therapy sessions.
  • Non-practice of regular physical activity.

Exclusion Criteria:

  • A history of surgery.
  • The presence of comorbid conditions (e.g., morbid obesity, inflammatory diseases, irritable bowel syndrome and interstitial cystitis).
  • A history of whiplash injury.
  • Severe physical disability.
  • uncontrolled endocrine disorders (e.g., hyperthyroidism, diabetes); 6) illness (e.g., schizophrenia or substance abuse).
  • The use of medication other than as-needed analgesics (excluding long-term narcotics).
  • Malignancy.
  • Psychiatric disorders.
  • A score of ≥ 9 points in the Beck depression inventory.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesio Taping and Inhibitory Treatment Techniques

During each session participants will receive the application kinesio taping in trapezius, infraspinatus and paravertebral muscles.

Inhibitory Treatment Techniques:

  • Release Technique of the trapezius muscle.
  • Release Technique for scalene muscles.
  • Technique suboccipital inhibition.
  • Technique hands crossed for induction dorsal superficial fascia.
Other: Kinesio Taping and Inhibitory Treatment Techniques

Kinesio Taping on trapezius, infraspinatus, and paravertebral muscles

Inhibitory Treatment Techniques:

  • Release Technique of the trapezius muscle.
  • Release Technique for scalene muscles.
  • Technique suboccipital inhibition.
  • Technique hands crossed for induction dorsal superficial fascia.
Active Comparator: Exercise and Electrical Stimulation Therapy
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.
Other: Exercise and Electrical Stimulation Therapy
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity
Time Frame: Changes from Baseline, and 10 weeks
A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.
Changes from Baseline, and 10 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Quality of Life (SF-36)
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Pittsburgh Quality of Sleep Questionnaire
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Beck Inventory for Depression
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Fibromyalgia Impact Questionnaire (FIQ)
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Hospital Anxiety Depression Scale (HADS)
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
State-Trait Anxiety Inventory (STAI)
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
McGill Pain Questionnaire
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Fatigue Impact Scale
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Pain Pressure
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Schöber Test
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Widespread pain index
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Symptom severity score
Time Frame: Changes from Baseline, and 10 weeks
Changes from Baseline, and 10 weeks
Measurement Finger-Floor
Time Frame: symptom severity scale
symptom severity scale

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universidad de Almeria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

November 1, 2020

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

August 4, 2016

First Submitted That Met QC Criteria

August 4, 2016

First Posted (Estimated)

August 9, 2016

Study Record Updates

Last Update Posted (Actual)

September 21, 2023

Last Update Submitted That Met QC Criteria

September 20, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UAL-496

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fibromyalgia

Clinical Trials on Kinesio Taping and Inhibitory Treatment Techniques

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe